ConductScience.org, home

Paper33972795

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

Mitchell JM and 37 others. Nat Med, 2021. Cited by 655 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Papers, record 33972795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33972795

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
PubMed
Journal
Nat Med
PubMed
Year
2021
PubMed
Publication types
Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
655
iCite
Relative citation ratio, by iCite
53.1
iCite
Revised in PubMed
2023-01-31
PubMed

Authors38

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mitchell JMJennifer Mhttps://orcid.org/0000-0002-7567-8129
2Bogenschutz MMichael
3Lilienstein AAlia
4Harrison CCharlotte
5Kleiman SSarah
6Parker-Guilbert KKelly
7Ot'alora G MMarcelahttps://orcid.org/0000-0001-6174-7317
8Garas WWael
9Paleos CCasey
10Gorman IIngmarhttps://orcid.org/0000-0003-4674-2969
11Nicholas CChristopher
12Mithoefer MMichael
13Carlin SShannon
14Poulter BBrucehttps://orcid.org/0000-0002-0489-2806
15Mithoefer AAnn
16Quevedo SSylvestre
17Wells GGregoryhttps://orcid.org/0000-0003-0902-5282
18Klaire SSSukhpreet S
19van der Kolk BBessel
20Tzarfaty KKeren

Source PubMed

See all 38 authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug-Related Side Effects and Adverse ReactionsMajor topic
N-Methyl-3,4-methylenedioxyamphetamineMajor topic
Stress Disorders, Post-TraumaticMajor topic
Adult
Combined Modality Therapy
Double-Blind Method
Female
Humans
Male
Middle Aged
Treatment Outcome

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R25 DA037756NIDA NIH HHSUnited StatesR25DA037756PubMed

Trials5

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03537014A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)ResultsYesClinicalTrials.gov
NCT05219175MDMA for Co-occurring PTSD and OUD After ChildbirthResultsClinicalTrials.gov
NCT05783817MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)ResultsClinicalTrials.gov
NCT05790239MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress DisorderBackgroundClinicalTrials.gov
NCT06954025High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSDResultsClinicalTrials.gov

Comments and corrections5

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in34,031,606Putting the MD back into MDMA.https://conductscience.org/library/papers/34031606PubMed
Comment in34,467,253Psychotherapy-supported MDMA treatment for PTSD.https://conductscience.org/library/papers/34467253PubMed
Comment in34,635,856Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy.https://conductscience.org/library/papers/34635856PubMed
Comment in34,635,857Challenges with benchmarking of MDMA-assisted psychotherapy.https://conductscience.org/library/papers/34635857PubMed
Comment in34,635,858Caution at psychiatry's psychedelic frontier.https://conductscience.org/library/papers/34635858PubMed

References1

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn Papers
110,450,264Posttraumatic stress disorder in abused and neglected children grown up.Am J Psychiatry1999https://conductscience.org/library/papers/10450264

Source PubMed

Cited by417

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 655 citations.

PMIDTitleJournalYearIn PapersSource
42,974,518Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation.Surg Neurol Int2026https://conductscience.org/library/papers/42974518PubMed
42,972,049A multi-institutional investigation of psilocybin's effects on mouse behavior.Nat Neurosci2026https://conductscience.org/library/papers/42972049PubMed
42,962,007The Fireside Database: Large-scale evidence from 25,419 psychedelic support interactions.Sci Adv2026https://conductscience.org/library/papers/42962007PubMed
42,891,831What goes up must comedown: prevalence rates, characteristics, and coping strategies concerning MDMA aftereffects.Psychopharmacology (Berl)2026https://conductscience.org/library/papers/42891831PubMed
42,875,076La psychothérapie assistée par des agents psychédéliques: Un paradigme émergent.Can Fam Physician2026https://conductscience.org/library/papers/42875076PubMed
42,875,067Psychedelic-assisted psychotherapy: Emerging paradigm.Can Fam Physician2026https://conductscience.org/library/papers/42875067PubMed
42,864,445Investigating molecular and hemodynamic effects of LSD in the human brain.Nat Neurosci2026https://conductscience.org/library/papers/42864445PubMed
42,860,436A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD.Neuropsychopharmacology2026https://conductscience.org/library/papers/42860436PubMed
42,852,177Understanding pharmaceutical industry coalitions: a case study of Mallinckrodt.Humanit Soc Sci Commun2026https://conductscience.org/library/papers/42852177PubMed
42,851,356Effects of psychedelic drug use on neurocognitive function and the psychological and social domains of quality of life: an international online study.Front Psychiatry2026https://conductscience.org/library/papers/42851356PubMed
42,818,834Exploring the potential of psychedelics in brain injury recovery: a thematic analysis of participant narratives.Front Neurol2026https://conductscience.org/library/papers/42818834PubMed
42,812,288Lived experience as systems-relevant evidence in psychedelic public health.Front Public Health2026https://conductscience.org/library/papers/42812288PubMed
42,653,026Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review.Life (Basel)2026https://conductscience.org/library/papers/42653026PubMed
42,639,859Feasibility, Safety, and Exploratory Outcomes of Methylphenidate for Posttraumatic Stress Disorder Among Patients With Ischemic Stroke.Int J Psychiatry Med2026https://conductscience.org/library/papers/42639859PubMed
42,625,872Priorities for public health preparedness for psychedelics: education, workforce readiness, and strategic information needs in a rapidly changing landscape.Front Public Health2026https://conductscience.org/library/papers/42625872PubMed
42,625,811Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review.Front Psychiatry2026https://conductscience.org/library/papers/42625811PubMed
42,581,324Well-being as a primary endpoint in clinical trials: a call for consensus.Npj Ment Health Res2026https://conductscience.org/library/papers/42581324PubMed
42,534,011Psychedelics for military and Veteran communities? Research, practice, and policy considerations.J Mil Veteran Fam Health2023https://conductscience.org/library/papers/42534011PubMed
42,533,988Mechanisms of integration in psychedelic-assisted therapy.J Mil Veteran Fam Health2023https://conductscience.org/library/papers/42533988PubMed
42,533,891A history and future of psychedelics: The case of the Canadian military.J Mil Veteran Fam Health2023https://conductscience.org/library/papers/42533891PubMed

See all 417 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
OXT5,020PubTator's text mininghttps://conductscience.org/library/genes/5020NCBI Gene
SLC6A46,532PubTator's text mininghttps://conductscience.org/library/genes/6532NCBI Gene

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
METHAMPHETAMINECHEMBL1201201Results1https://conductscience.org/library/drugs/CHEMBL1201201ChEMBL
MIDOMAFETAMINECHEMBL43048Results4https://conductscience.org/library/drugs/CHEMBL43048ChEMBL

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33972795

GET https://conductscience.org/api/papers/v1/33972795/authors?page=2